Delivery Order SPE2DB22D9244-SPE2DB24FZS76
- Not listed
- This federal contract award, valued at $4,420.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of TESTOPEL 75 MG PELLETS 10S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,420.40 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product, with a period of performance through April 28, 2023. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,420.40 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 10S, with a period of performance through November 28, 2022. This award falls under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,430.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of November 17, 2021, is for the supply of the drug TESTOPEL 75 MG PELLETS 10S. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
- This federal contract award, SPE2DB20D9331|SPE2DB23FL1H0, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,840.80 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 10S, with an ultimate completion date of August 21, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This firm fixed-price delivery order contract, valued at $10,608.96, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA,...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,094.28 contract is for the delivery of a specialized pharmaceutical product, TESTOPEL 75MG PELL 10S, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. This delivery order is part of a larger...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $4,420.40 contract is for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product, to the DLA. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31, 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,261.20, is a delivery order under the DLA's SPE2DB program, which is an indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. The delivery order is for the product "TESTOPEL 75 MG PELLETS 10S" with a completion date of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,420.40, is for the delivery of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product. The contract is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB24FZS76Delivery Order
This federal contract award, valued at $8,840.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This particular award is part of this larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain. The contract has no set-aside designation and is intended to support the medical supply requirements of the Department of Defense (DoD) healthcare facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 9/9/24 |